{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:19:49Z","timestamp":1773415189791,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science, Research, and Innovation Fund","award":["195616"],"award-info":[{"award-number":["195616"]}]},{"name":"National Science, Research, and Innovation Fund","award":["195616"],"award-info":[{"award-number":["195616"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11648-7","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:38:30Z","timestamp":1773401910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enzalutamide effectively inhibits the growth of meningiomas via p21-dependent senescence induction"],"prefix":"10.1007","volume":"53","author":[{"given":"Thanawat","family":"Trasaktaweesakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pundit","family":"Asavaritikrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phattrara","family":"Khuansonthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pitchanun","family":"Jaturutthaweechot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nopporn","family":"Naewwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krajang","family":"Talabnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chutima","family":"Talabnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"11648_CR1","doi-asserted-by":"publisher","first-page":"IV1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G et al (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro Oncol 22:IV1\u2013IV96. https:\/\/doi.org\/10.1093\/neuonc\/noaa200","journal-title":"Neuro Oncol"},{"key":"11648_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314. https:\/\/doi.org\/10.1007\/s11060-010-0386-3","journal-title":"J Neurooncol"},{"key":"11648_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.wneu.2024.03.051","volume":"186","author":"T Han","year":"2024","unstructured":"Han T, Liu X, Zhou J (2024) Progression\/recurrence of meningioma: an imaging review based on magnetic resonance imaging. World Neurosurg 186:98\u2013107. https:\/\/doi.org\/10.1016\/j.wneu.2024.03.051","journal-title":"World Neurosurg"},{"key":"11648_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-006-9146-9","volume":"80","author":"K Korhonen","year":"2006","unstructured":"Korhonen K, Salminen T, Raitanen J et al (2006) Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80:1\u20137. https:\/\/doi.org\/10.1007\/s11060-006-9146-9","journal-title":"J Neurooncol"},{"key":"11648_CR5","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s10552-010-9634-2","volume":"21","author":"K Korhonen","year":"2010","unstructured":"Korhonen K, Raitanen J, Isola J et al (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21:2149\u20132156. https:\/\/doi.org\/10.1007\/s10552-010-9634-2","journal-title":"Cancer Causes Control"},{"key":"11648_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10552-011-9742-7","volume":"22","author":"A Cowppli-Bony","year":"2011","unstructured":"Cowppli-Bony A, Bouvier G, Ru\u00e9 M et al (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22:697\u2013714. https:\/\/doi.org\/10.1007\/s10552-011-9742-7","journal-title":"Cancer Causes Control"},{"key":"11648_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin C, Perry A (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99:379\u2013391. https:\/\/doi.org\/10.1007\/s11060-010-0342-2","journal-title":"J Neurooncol"},{"key":"11648_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlx008","author":"C Boulagnon-Rombi","year":"2017","unstructured":"Boulagnon-Rombi C, Fleury C, Fichel C et al (2017) Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics. J Neuropathol Exp Neurol. https:\/\/doi.org\/10.1093\/jnen\/nlx008","journal-title":"J Neuropathol Exp Neurol"},{"key":"11648_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1440-1789.2009.01047.x","volume":"30","author":"CGS Le\u00e3es","year":"2010","unstructured":"Le\u00e3es CGS, Meurer RT, Coutinho LB et al (2010) Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. Neuropathology 30:44\u201349. https:\/\/doi.org\/10.1111\/j.1440-1789.2009.01047.x","journal-title":"Neuropathology"},{"key":"11648_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030980","author":"M Agopiantz","year":"2023","unstructured":"Agopiantz M, Carnot M, Denis C et al (2023) Hormone receptor expression in meningiomas: a systematic review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15030980","journal-title":"Cancers (Basel)"},{"key":"11648_CR11","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.wneu.2020.04.168","volume":"140","author":"S Portet","year":"2020","unstructured":"Portet S, Banor T, Bousquet J et al (2020) New insights into expression of hormonal receptors by meningiomas. World Neurosurg 140:e87\u2013e96. https:\/\/doi.org\/10.1016\/j.wneu.2020.04.168","journal-title":"World Neurosurg"},{"key":"11648_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/nejmoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher HI, Fizazi K, Saad F et al (2012) Increased survival with Enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367:1187\u20131197. https:\/\/doi.org\/10.1056\/nejmoa1207506","journal-title":"N Engl J Med"},{"key":"11648_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.1168175","volume":"324","author":"C Tran","year":"2009","unstructured":"Tran C, Ouk S, Clegg NJ et al (2009) Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science (1979) 324:787\u2013790. https:\/\/doi.org\/10.1126\/science.1168175","journal-title":"Science (1979)"},{"key":"11648_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9030021","author":"B Rahim","year":"2017","unstructured":"Rahim B, O\u2019Regan R (2017) AR signaling in breast cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers9030021","journal-title":"Cancers (Basel)"},{"key":"11648_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5534\/wjmh.180040","volume":"37","author":"K Fujita","year":"2019","unstructured":"Fujita K, Nonomura N (2019) Role of androgen receptor in prostate cancer: a review. World J Men?s Health 37:288\u2013295. https:\/\/doi.org\/10.5534\/wjmh.180040","journal-title":"World J Men?s Health"},{"key":"11648_CR16","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1530\/ERC-14-0543","volume":"22","author":"T Proverbs-Singh","year":"2015","unstructured":"Proverbs-Singh T, Feldman JL, Morris MJ et al (2015) Targeting the androgen receptor in prostate and breast cancer: several new agents in development. Endocr Relat Cancer 22:R87\u2013R106. https:\/\/doi.org\/10.1530\/ERC-14-0543","journal-title":"Endocr Relat Cancer"},{"key":"11648_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40262-015-0271-5","volume":"54","author":"JA Gibbons","year":"2015","unstructured":"Gibbons JA, Ouatas T, Krauwinkel W et al (2015) Clinical pharmacokinetic studies of Enzalutamide. Clin Pharmacokinet 54:1043\u20131055. https:\/\/doi.org\/10.1007\/s40262-015-0271-5","journal-title":"Clin Pharmacokinet"},{"key":"11648_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104142","author":"X Gan","year":"2023","unstructured":"Gan X, Liu Y, Wang X (2023) Targeting androgen receptor in glioblastoma. Crit Rev Oncol Hematol. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104142","journal-title":"Crit Rev Oncol Hematol"},{"key":"11648_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-023-00959-5","author":"SCR Williams","year":"2023","unstructured":"Williams SCR, Mazibuko N, O\u2019Daly O et al (2023) Comparison of cerebral blood flow in regions relevant to cognition after Enzalutamide, Darolutamide, and Placebo in healthy volunteers: a randomized crossover trial. Target Oncol. https:\/\/doi.org\/10.1007\/s11523-023-00959-5","journal-title":"Target Oncol"},{"key":"11648_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.616625","author":"N Zhao","year":"2021","unstructured":"Zhao N, Wang F, Ahmed S et al (2021) Androgen receptor, although not a specific marker for, is a novel target to suppress glioma stem cells as a therapeutic strategy for glioblastoma. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.616625","journal-title":"Front Oncol"},{"key":"11648_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196666","author":"CY Chang","year":"2022","unstructured":"Chang CY, Chen JT, Chen TH, Chen RM (2022) Enzalutamide induces apoptotic insults to human drug-resistant and -sensitive glioblastoma cells via an intrinsic Bax-Mitochondrion-Cytochrome C caspase cascade activation pathway. Molecules. https:\/\/doi.org\/10.3390\/molecules27196666","journal-title":"Molecules"},{"issue":"3","key":"11648_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s13577-025-01211-0","volume":"38","author":"T Trasaktaweesakul","year":"2025","unstructured":"Trasaktaweesakul T, Asavaritikrai P, Talabnin K et al (2025) In vitro properties of four benign meningioma cells derived from WHO grade 1 meningiomas. Hum Cell 38:84. https:\/\/doi.org\/10.1007\/s13577-025-01211-0","journal-title":"Hum Cell"},{"key":"11648_CR23","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16785","author":"C Talabnin","year":"2024","unstructured":"Talabnin C, Trasaktaweesakul T, Jaturutthaweechot P et al (2024) Altered O-linked glycosylation in benign and malignant meningiomas. PeerJ. https:\/\/doi.org\/10.7717\/peerj.16785","journal-title":"PeerJ"},{"key":"11648_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78798-x","author":"R Smith","year":"2020","unstructured":"Smith R, Liu M, Liby T et al (2020) Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-78798-x","journal-title":"Sci Rep"},{"key":"11648_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1158\/0008-5472.CAN-22-1016","volume":"83","author":"L Wei","year":"2023","unstructured":"Wei L, Gao H, Yu J et al (2023) Pharmacological targeting of androgen receptor elicits context-specific effects in estrogen receptor\u2013positive breast cancer. Cancer Res 83:456\u2013470. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1016","journal-title":"Cancer Res"},{"key":"11648_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06003-0","author":"JW Magrath","year":"2024","unstructured":"Magrath JW, Goldberg IN, Truong DD et al (2024) Enzalutamide induces cytotoxicity in desmoplastic small round cell tumor independent of the androgen receptor. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-024-06003-0","journal-title":"Commun Biol"},{"key":"11648_CR27","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.4161\/cc.22937","volume":"11","author":"OV Leontieva","year":"2012","unstructured":"Leontieva OV, Lenzo F, Demidenko ZN, Blagosklonny MV (2012) Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 11:4642\u20134649. https:\/\/doi.org\/10.4161\/cc.22937","journal-title":"Cell Cycle"},{"key":"11648_CR28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/cdd.2013.86","volume":"20","author":"OV Leontieva","year":"2013","unstructured":"Leontieva OV, Demidenko ZN, Blagosklonny MV (2013) MEK drives cyclin D1 hyperelevation during geroconversion. Cell Death Differ 20:1241\u20131249. https:\/\/doi.org\/10.1038\/cdd.2013.86","journal-title":"Cell Death Differ"},{"key":"11648_CR29","doi-asserted-by":"publisher","unstructured":"Wang L, Han H, Dong L et al (2021) Function of p21 and its therapeutic effects in esophageal cancer (Review). Oncol Lett 21. https:\/\/doi.org\/10.3892\/ol.2020.12397","DOI":"10.3892\/ol.2020.12397"},{"key":"11648_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2024.100113","author":"J Yan","year":"2024","unstructured":"Yan J, Chen S, Yi Z et al (2024) The role of p21 in cellular senescence and aging-related diseases. Mol Cells. https:\/\/doi.org\/10.1016\/j.mocell.2024.100113","journal-title":"Mol Cells"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11648-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:38:31Z","timestamp":1773401911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11648-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11648"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11648-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}